Medical Community
Cyberknife® System  >>
How Cyberknife® 
How is Cyberknife®
Cyberknife® indications  >>
Conditions Cyberknife®
can treat  >>
Treatment Process  >>
Benefits of Cyberknife®  >>
Download the patient
referral form  
Common conditions treatable
  Astrocytoma, glioma, glioblastoma multiforme, oligodendroglioma - CyberKnife® offers superior conformance to tumour shape, which is important especially for recurrence after surgery and conventional radiotherapy. CyberKnife® can also irradiate the tumour bed to delay or prevent recurrence.
  Brain metastases - Radiosurgery may be equal to surgery for single metastases and better for multiple metastases. Advanced imaging allows CyberKnife® to treat those that are widely dispersed.
  Spinal tumours - CyberKnife® is regularly used to treat spinal
metastases. It may also serve as a treatment for many primary spinal tumours.
  Pituitary adenoma - CyberKnife’s® staged treatments may help to avoid or minimize the risk of visual loss and other side effects associated with single-session radiosurgery. Its superior conformance minimizes irradiation of normal tissue, including the optic chiasm and hypothalamus.
  Hemangioblastoma - CyberKnife® non-invasively treats the tumour nodule, usually in one session, even in hard-to-reach areas. This is especially beneficial for Von Hippel Lindau disease patients who can become disabled by multiple surgeries.
  Skull base tumours - The proximity of these tumours to vital nerve and vascular structures makes them surgically problematic.
  Chordoma - Since chordomas are relatively radioresistant and close to vital structures, they were frequently labeled as untreatable. Superior conformance and staged sessions permit higher doses therefore. CyberKnife® should be considered as a primary treatment option, the treatment of choice by now.
  Meningioma - For smaller meningiomas, radiosurgery is an ideally non-invasive therapy. CyberKnife® is especially safe for meningiomas adjacent to critical structures because it can be delivered in fractions.
  Neurofibroma & Schwannoma - While these tumours’ resistance to radiation makes conventional radiotherapy an option only when surgery is not, CyberKnife’s® conformance makes it an effective alternative to radiation therapy and surgery for selected patients.
  Acoustic neuroma - Studies show that CyberKnife® treatment in stages offers the highest rates ever achieved for hearing and facial-nerve preservation besides effective control of the tumour-growth.
  Intracranial AVMs - With CyberKnife®, we can treat locations that can’t be safely approached with microsurgery or endovascular therapy. Selected AVMs have an 80% chance of disappearing after a single treatment session though it may take some time. CyberKnife® can also be used in conjunction with other therapies to remove remnants.
  Spinal AVMs - CyberKnife® is the first and the only system to offer radiosurgical treatment of spinal AVMs .It provides the same or even more accuracy and success as for intracranial AVMs.
  Trigeminal neuralgia - Unlike invasive therapies and conventional radiotherapy, CyberKnife® is painless, frameless and less risky to be used in functional Neurological conditions like in Trigeminal neuralgia.
Common conditions | » Head and neck | » Gastrointestinal Tract | » Urology
Home  |  Contact  
Apollo Hospitals  >>  Apollo Speciality Cancer Hospital  >> << Click here to view Cyberknife Blog >>